Your browser doesn't support javascript.
loading
Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction: 1-year results of the randomized AIDA STEMI trial.
Desch, Steffen; Wöhrle, Jochen; Hambrecht, Rainer; Rittger, Harald; Birkemeyer, Ralf; Lauer, Bernward; Neuhaus, Petra; Brosteanu, Oana; Sick, Peter; Pauschinger, Matthias; Kerber, Sebastian; Kleinertz, Klaus; de Waha, Suzanne; Eitel, Ingo; Schuler, Gerhard; Thiele, Holger.
Affiliation
  • Desch S; University of Leipzig Heart Center, Department of Internal Medicine/Cardiology, Leipzig, Germany. Electronic address: stdesch@web.de.
J Am Coll Cardiol ; 62(13): 1214-5, 2013 Sep 24.
Article in En | MEDLINE | ID: mdl-23850911

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Fab Fragments / Platelet Aggregation Inhibitors / Antibodies, Monoclonal / Myocardial Infarction Type of study: Clinical_trials Limits: Humans Language: En Journal: J Am Coll Cardiol Year: 2013 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Fab Fragments / Platelet Aggregation Inhibitors / Antibodies, Monoclonal / Myocardial Infarction Type of study: Clinical_trials Limits: Humans Language: En Journal: J Am Coll Cardiol Year: 2013 Document type: Article Country of publication: United States